Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

December 2, 2009
Otsuka Pharmaceutical

Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration
November 25, 2009
Otsuka Pharmaceutical

U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
November 13, 2009
Otsuka Holdings

Otsuka Holdings announces “Research and Development” website opens November 13, 2009
November 12, 2009
Otsuka Chemical

Otsuka Foods and Otsuka Beverage to merge
October 28, 2009
Otsuka Pharmaceutical Factory

HINE® Jelly AQUA Concentrated liquid nutrition product to be launched on November 4, 2009
October 9, 2009
Otsuka Holdings

Otsuka Holdings receives The 2009 Investor in France Award October 8, 2009
September 28, 2009
Otsuka Pharmaceutical Factory

ELNEOPA No. 1 Injection & ELNEOPA No. 2 Injection - the world's first TPN* solution formulated with five types of trace elements- to be launched September 28, 2009 in Japan
September 8, 2009
Otsuka Pharmaceutical

New addition to CalorieMate® line of balanced nutrition blocks CalorieMate® Block, Maple Flavor First new flavor in two years debuts September 29
August 26, 2009
Otsuka Pharmaceutical

New SOYJOY flavored with blueberries and white chocolate chips SOYJOY Blueberry Debuts September 29, 2009
August 17, 2009
Otsuka Pharmaceutical

Otsuka Pharmaceutical Supports 8th Annual Wheelchair Basketball Camp in Ibaraki held from August 14-16, 2009
August 14, 2009
Otsuka Pharmaceutical

20th Annual Outdoor Concert Held at Otsuka Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki'09 on August 13, 2009
August 4, 2009
Otsuka Pharmaceutical

The European Commission Approves SAMSCA™ (tolvaptan), Europe's First and Only Oral Vasopressin Antagonist for Hyponatraemia Secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) .
August 3, 2009
Taiho Pharmaceutical

Taiho to Buy Tsukuba Research Institute from Banyu
July 21, 2009
Taiho Pharmaceutical

Taiho Pharmaceutical's Anticancer Agent TS-1 Approved for Market in Singapore
July 13, 2009
Otsuka Pharmaceutical

Pocari Sweat in 900ml PET Eco-bottles New lightweight eco-bottles achieve 30% reduction in packaging weight
June 19, 2009
Otsuka Pharmaceutical

Fiscal Year through March 2009 Non-consolidated Results of Otsuka Pharmaceutical Co., Ltd.
June 19, 2009
Otsuka Pharmaceutical

Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors
May 21, 2009
Otsuka Pharmaceutical

FDA Approves SAMSCA™ (tolvaptan), The First and Only Oral Vasopressin Antagonist to Treat Patients with Clinically Significant Hypervolemic and Euvolemic Hyponatremia
May 15, 2009
Otsuka Holdings

Fiscal Year through March 2009 – Consolidated Results
May 8, 2009
Otsuka Holdings

Announcement regarding the conversion of Otsuka Chemical Holdings into a wholly owned subsidiary of Otsuka Holdings
April 6, 2009
Otsuka Pharmaceutical

Otsuka and Bristol-Myers Squibb Extend U.S. Agreement for ABILIFY and Establish a Global Oncology Collaboration
April 6, 2009
Otsuka Pharmaceutical

Otsuka Pharmaceutical Special Sponsorship Pocari Sweat U-12 Soccer League
March 31, 2009
Taiho Pharmaceutical

Taiho Pharmaceutical and PharmaMar of Spain Sign License Agreement on Antitumor Agent Yondelis® (Trabectedin)
March 31, 2009
Otsuka Pharmaceutical

20th Anniversary Edition Published March 31 OTSUKA Health Comic Library Sequel Vol. 2 "Explore! All About Our Bodies" Educational comic series donated to elementary schools nationwide
March 26, 2009
Otsuka Pharmaceutical

Make-up removers formulated with moisturizing ingredient AMP expand the InnerSignal line of skin care products gentle, thorough removal of sebum and makeup
March 25, 2009
Otsuka Pharmaceutical

Antipsychotic agent ABILIFY® Oral Solution 0.1% to be Launched on April 10, 2009 in Japan
March 12, 2009
Otsuka Pharmaceutical

Otsuka Pharmaceutical Supports Anti-Doping Efforts through Participation in “ Pharmacist” Project
March 11, 2009
Taiho Pharmaceutical

Taiho Pharmaceutical and Toray Industries Now Working Together to Develop a ß3-Adrenoceptor Agonist
February 26, 2009
Otsuka Pharmaceutical

Third product in fruit soy bar SOYJOY 'Plus' series SOYJOY Banana Calcium Plus Debuts April 1, 2009
February 25, 2009
Otsuka Pharmaceutical

Produced by Amino-Value “Virtual Tokyo Marathon 2009” Select your favorite avatar and challenge the 42.195km run